Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
23 April 2022 - L0195
Factors associated with clinical success in treatment with imipenem-cilastatin-relebactam
Nicholas Rebold, Sara Alosaimy, Dana Holger, Kristen Lucas, Yi Guo, Mei Chang, Mark Biagi, Travis Carlson, Jeremy Frens, Katie Barber, Julie Justo, Jillian Hayes, Amy Carr, Wesley Kufel, William Moore, Kristen Zeitler, Taylor Morrisette, Michael Rybak
23 April 2022 - L0196
Efficacy assessment of ibrexafungerp in the neutropenic mouse model of pulmonary mucormycosis
Teclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, Laura Najvar, Nathan Wiederhold, Thomas Patterson, Scott Filler, Ashraf Ibrahim
23 April 2022 - P1390
Efficacies of two novel broad-spectrum antiseptic-based antimicrobials for the therapeutic treatment of antimicrobial resistant pathogens causing surgical/non-surgial wound infections
Ellen Benn, Shanom Ali
23 April 2022 - P1396
Safety, efficacy, and pharmacokinetics of ceftolozane/tazobactam versus meropenem in neonates and young infants with complicated urinary tract infection, including pyelonephritis
Emmanuel Roilides, John S. Bradley, Sumit Basu, Julia Lonchar, Jennifer A. Huntington, Jason Chittenden, Nadia Noormohamed, Christopher J. Bruno, Matthew G. Johnson
23 April 2022 - P1397
Efficacy and safety of sulbactam-durlobactam (SUL-DUR) therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections in the open label part B of the ATTACK phase III trial
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah Mcleod, Khurram Rana, Gabrielle Poirier, Andrew Shorr, Keith Kaye
23 April 2022 - P1399
A phase I study of the safety, tolerability, and pharmacokinetics of the Novomixin QPX9003 in healthy adult subjects
David Griffith, Yehuda Carmeli, Shawnee Gehrke, Elizabeth Morgan, Michael Dudley, Jeffery Loutit
23 April 2022 - P1398
Efficacy and safety of intravenous sulopenem followed by oral sulopenem etzadroxil/probenecid versus intravenous ertapenem followed by oral ciprofloxacin and metronidazole or amoxicillin-clavulanate in the treatment of complicated intra-abdominal infectio
Steven Aronin, Jeanne Breen, Michael Dunne, Sailaja Puttagunta
23 April 2022 - P1392
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multi-centre retrospective observational study
Marianna Meschiari, Carlotta Rogati, Stefania Casolari, Paolo Bassi, Daniele Roberto Ciacobbe, Matteo Bassetti, Simone Mornese Pinna, Francesco Giuseppe De Rosa, Francesco Barchiesi, Carolina Lorusso, Giovanni Cenderello, Cristina Mussini
23 April 2022 - P1391
Efficacy of cefiderocol in patients with nosocomial pneumonia and complicated urinary tract infections caused by Enterobacterales and carbapenem-resistant Enterobacterales (CREs) from three randomised clinical trials
Thierry Naas, Jason M Pogue, Keith S Kaye, Takamichi Baba, Anju Menon, Roger Echols, Yoshinori Yamano, Christopher Longshaw, Simon Portsmouth
23 April 2022 - P1393
Evaluation of the Oxoid Lefamulin 20 µg Antimicrobial Susceptibility Testing (AST) Disc against the hardy Lefamulin 20 µg AST Disc
Amie Lovatt, Nicole Holliday, Cindy Knapp, Edward Best, Susanne Paukner, Katie Simpson, Jill Lindley, Dee Shortridge
23 April 2022 - P1395
Safety profile of sulbactam-durlobactam (SUL-DUR) versus colistin therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections from the phase III, global, randomised, active-controlled trial (ATTACK)
Drew Lewis, Khurram Rana, Melissa Steidler, Gabrielle Poirier, David Altarac
23 April 2022 - P1394
Single-centre UK experience of once weekly dalbavancin for the treatment of invasive Gram-positive infections in vulnerable groups
Benedict Porter, Susanne Hodgson, Lorna Masson, Louise Dunsmure, Nicole Stoesser
09 July 2021 - 4507
Cefiderocol as rescue therapy for carbapenem-resistant Gram-negative infections in ICU patients: early single-centre experience, Pisa, Italy (2020)
Marco Falcone, M. Falcone (1), G. Tiseo (1), L. Della Sala (1), A. Leonildi (2), C. Giordano (2), A. Vecchione (2), S. Barnini (2), F. Menichetti (1)
09 July 2021 - 3717
Bacteriocin production in CoNS and CoPS isolates with antimicrobial activity against relevant pathogens
Rosa Fernández-Fernández, R. Fernández-Fernández (1), L. Ruiz-Ripa (1), S. García-Vela (1), S. Martínez-Álvarez (1), M. Sadi (1, 2), M. Zarazaga (1), C. Lozano (1), C. Torres (1)
09 July 2021 - 3899
Meropenem/fosfomycin combination: an effective treatment for carbapenem-resistant complicated urinary tract infections from both in vitro evaluation and clinical case study
Luiz Jorge Moreira Neto, L.J. Moreira Neto, J. Albiero, N.H. Fedrigo, D.R. Shinohara, J. Mazucheli, S.K. Sy, M.C. Bronharo Tognim
09 July 2021 - 3523
Influence of tedizolid on circulating cytokines in the human lipopolysaccharide challenge
Anselm Jorda, A. Jorda (1), B. Wulkersdorfer (1), C. Schörgenhofer (1), P. Matzneller (1), V. Al Jalali (1), M. Bauer (1), E. Lackner (1), C. Dorn (2), B. Jilma (1), M. Zeitlinger (1)
09 July 2021 - 3231
Drug repurposing as an effective strategy to treat multidrug-resistant infections: “Teaching old drugs new tricks”
Daniela Alves Ferreira, D. Alves Ferreira, M. Martins
09 July 2021 - 2973
Fosfomycin use in the treatment of periprosthetic joint infection (PJI): a first impression in the Netherlands
Denise Telgt, D. Telgt, K. Spijkers, K. Veerman, F. Vos, M. Nabuurs-Franssen, J. Goosen
09 July 2021 - 2507
Real-world, multi-centre experience with eravacycline for complicated infections
Sara Alosaimy, S. Alosaimy (1), J. Bouchard (2), S.L. Kang-Birken (3), K.C. Molina (4), A.L. Hobbs (5), N.B. Perkins Iii (6), K.C. Claeys (7), M.A. King (8), B.M. Pullinger (8), M. Veve (1), S. Tart (9), M. Biagi (10), M. Pierce (10), L.M. Rojas (11), B.M. Jones (12), J. Truong (13), J. Andrade (13), R. Cosimi (14), G. Huang (15), A.M. Lagnf (1), T. Morrisette (1), D. Holger (1), N. Rebold (1), S.L. Davis L (1), M.J. Rybak (1)
09 July 2021 - 655
Imipenem/cilastatin/relebactam efficacy, safety, and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia and renal impairment or augmented renal clearance
Luke Chen, L. Chen, M.C. Losada, J. Du, C.A. De Ryke, M. Patel, A. Paschke
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.